ISSN:
1573-0646
Schlagwort(e):
n-methylformamide
;
spirogermanium
;
small cell lung cancer
Quelle:
Springer Online Journal Archives 1860-2000
Thema:
Chemie und Pharmazie
,
Medizin
Notizen:
Summary Fifty-four evaluable patients with SCLC previously treated with chemotherapy received either N-methylformamide or spirogermanium. There was one partial response to N-methylformamide. The median survival times for patients treated with N-MF and spirogermanium were 11.7 and 12.6 weeks respectively. Five patients treated with N-MF experienced severe toxicity while four patients treated with spirogermanium experienced severe and life-threatening toxicity.
Materialart:
Digitale Medien
URL:
http://dx.doi.org/10.1007/BF00177255
Permalink